Morgan Stanley Geron Corp Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Geron Corp stock. As of the latest transaction made, Morgan Stanley holds 13,295,442 shares of GERN stock, worth $18.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,295,442

Previous 11,534,238 15.27%

Holding current value

$18.3 Million

Previous $18.3 Million 2.22%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	BUY	$1.18 - $1.62 $2.08 Million - $2.85 Million	1,761,204 Added 15.27%	13,295,442 $18.7 Million
Q1 2025 May 15, 2025	SELL	$1.59 - $3.6 $243,435 - $551,174	-153,104 Reduced 1.31%	11,534,238 $18.3 Million
Q4 2024 Feb 14, 2025	BUY	$3.3 - $4.44 $30 Million - $40.4 Million	9,092,165 Added 350.35%	11,687,342 $41.4 Million
Q3 2024 May 14, 2025	BUY	$4.17 - $4.99 $4.18 Million - $5 Million	1,002,009 Added 62.89%	2,595,177 $11.8 Million
Q3 2024 Nov 14, 2024	BUY	$4.17 - $4.99 $4.18 Million - $5 Million	1,002,009 Added 62.89%	2,595,177 $11.8 Million
Q2 2024 May 14, 2025	SELL	$3.1 - $5.09 $31.3 Million - $51.4 Million	-10,094,174 Reduced 86.37%	1,593,168 $6.76 Million
Q2 2024 Oct 17, 2024	SELL	$3.1 - $5.09 $5.46 Million - $8.96 Million	-1,760,972 Reduced 52.5%	1,593,168 $6.76 Million
Q2 2024 Aug 14, 2024	SELL	$3.1 - $5.09 $5.46 Million - $8.96 Million	-1,760,972 Reduced 52.5%	1,593,168 $6.76 Million
Q1 2024 Oct 17, 2024	BUY	$1.75 - $3.44 $3.08 Million - $6.06 Million	1,760,972 Added 110.53%	3,354,140 $11.1 Million
Q1 2024 Aug 16, 2024	SELL	$1.75 - $3.44 $12.6 Million - $24.8 Million	-7,210,127 Reduced 68.25%	3,354,140 $11.1 Million
Q1 2024 May 15, 2024	SELL	$1.75 - $3.44 $12.6 Million - $24.8 Million	-7,210,127 Reduced 68.25%	3,354,140 $11.1 Million
Q4 2023 Aug 16, 2024	BUY	$1.74 - $2.31 $15.6 Million - $20.7 Million	8,971,099 Added 563.1%	10,564,267 $22.3 Million
Q4 2023 Feb 13, 2024	BUY	$1.74 - $2.31 $16 Million - $21.3 Million	9,199,235 Added 673.92%	10,564,267 $22.3 Million
Q3 2023 Nov 15, 2023	BUY	$2.11 - $3.28 $1.29 Million - $2 Million	609,794 Added 80.74%	1,365,032 $2.89 Million
Q2 2023 Aug 14, 2023	SELL	$1.97 - $3.69 $706,534 - $1.32 Million	-358,647 Reduced 32.2%	755,238 $2.42 Million
Q1 2023 May 15, 2023	BUY	$2.14 - $3.4 $1.12 Million - $1.77 Million	521,985 Added 88.19%	1,113,885 $2.42 Million
Q4 2022 Feb 14, 2023	SELL	$2.03 - $2.42 $172,736 - $205,922	-85,092 Reduced 12.57%	591,900 $1.43 Million
Q3 2022 Nov 14, 2022	SELL	$1.67 - $2.94 $264,384 - $465,443	-158,314 Reduced 18.95%	676,992 $1.58 Million
Q2 2022 Oct 27, 2022	BUY	$1.19 - $1.65 $73,224 - $101,529	61,533 Added 7.95%	835,306 $1.29 Million
Q2 2022 Aug 15, 2022	BUY	$1.19 - $1.65 $73,224 - $101,529	61,533 Added 7.95%	835,306 $1.29 Million
Q1 2022 Oct 27, 2022	SELL	$0.99 - $1.6 $60,917 - $98,452	-61,533 Reduced 7.37%	773,773 $1.05 Million
Q1 2022 May 13, 2022	BUY	$0.99 - $1.6 $470,607 - $760,577	475,361 Added 159.3%	773,773 $1.05 Million
Q4 2021 Feb 14, 2022	SELL	$1.22 - $1.72 $23,805 - $33,562	-19,513 Reduced 6.14%	298,412 $365,000
Q3 2021 Nov 15, 2021	BUY	$1.2 - $1.5 $381,510 - $476,887	317,925 New	317,925 $435,000

Others Institutions Holding GERN

# of Institutions

282

Shares Held

509M

Call Options Held

884K

Put Options Held

564K

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $521M
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account